AMN vs. CGON, PRVA, MRVI, GH, STAA, DYN, GERN, APGE, RXST, and NTLA
Should you be buying AMN Healthcare Services stock or one of its competitors? The main competitors of AMN Healthcare Services include CG Oncology (CGON), Privia Health Group (PRVA), Maravai LifeSciences (MRVI), Guardant Health (GH), STAAR Surgical (STAA), Dyne Therapeutics (DYN), Geron (GERN), Apogee Therapeutics (APGE), RxSight (RXST), and Intellia Therapeutics (NTLA). These companies are all part of the "medical" sector.
CG Oncology (NASDAQ:CGON) and AMN Healthcare Services (NYSE:AMN) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, community ranking, profitability, institutional ownership, valuation, risk, dividends and media sentiment.
26.6% of CG Oncology shares are owned by institutional investors. Comparatively, 99.2% of AMN Healthcare Services shares are owned by institutional investors. 0.9% of AMN Healthcare Services shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
CG Oncology presently has a consensus target price of $63.75, suggesting a potential upside of 115.37%. AMN Healthcare Services has a consensus target price of $75.57, suggesting a potential upside of 28.63%. Given AMN Healthcare Services' stronger consensus rating and higher possible upside, equities analysts plainly believe CG Oncology is more favorable than AMN Healthcare Services.
AMN Healthcare Services received 430 more outperform votes than CG Oncology when rated by MarketBeat users. However, 80.00% of users gave CG Oncology an outperform vote while only 68.98% of users gave AMN Healthcare Services an outperform vote.
AMN Healthcare Services has higher revenue and earnings than CG Oncology.
In the previous week, AMN Healthcare Services had 9 more articles in the media than CG Oncology. MarketBeat recorded 20 mentions for AMN Healthcare Services and 11 mentions for CG Oncology. CG Oncology's average media sentiment score of 0.45 beat AMN Healthcare Services' score of 0.25 indicating that AMN Healthcare Services is being referred to more favorably in the news media.
AMN Healthcare Services has a net margin of 4.13% compared to AMN Healthcare Services' net margin of 0.00%. CG Oncology's return on equity of 31.39% beat AMN Healthcare Services' return on equity.
Summary
AMN Healthcare Services beats CG Oncology on 10 of the 14 factors compared between the two stocks.
Get AMN Healthcare Services News Delivered to You Automatically
Sign up to receive the latest news and ratings for AMN and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding AMN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
AMN Healthcare Services Competitors List
Related Companies and Tools
